Clinical Trial Update: Nebulised 3% Hypertonic Saline in Infants With Acute Bronchiolitis [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on nebulised 3% hypertonic saline for infants with acute bronchiolitis; the Phase 2/3 study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis

Drugs mentioned

• Nebulised 3% Hypertonic Saline (3% hypertonic saline for nebulization)

Snippet

Sponsor: Can Tho University of Medicine and Pharmacy | Conditions: Acute Bronchiolitis | Phase 2, Phase 3 | Status: COMPLETED